Tag Archives: drug safety

Why You Need to Rethink Your 2010 Strategy

By Sven Larsen (@zemoga) What will the Pharma industry be like in 2010? Even though there are only 10 days left in 2009 I don't think that's a question anyone can accurately answer. Not because...
Posted in Digital Health, Social Media | Tagged , , , , , , | Leave a comment

What’s Your Pharma Wishlist for 2010?

By Sven Larsen (@zemoga) Do you have all your holiday shopping done yet? if you're like most of us you've probably received wish lists from your friends and family, so you know what kind of gifts...
Posted in Digital Health, Social Media | Tagged , , , , , , , , , , , , , | Leave a comment

How Can Pharma Communicate Better?

By Guy Mastrion (@gmastrion) We've been grousing about how pharma doesn't take its own reputation seriously enough. So we decided, okay, let's be productive and think of ways to better that. First...
Posted in Social Media | Tagged , , , , , , , , , , | Leave a comment

What is the Future of DTC Advertising?

By Steve Dubansky, MD Are you ready for 10 minute long DTC commercials? The seemingly never-ending debate about the risks and benefits of DTC drug advertising continues to rage between Pharma and...
Posted in Social Media | Tagged , , , , , , , , , , , , , , | 3 Comments

Paul Roellig of BulletinNEWS on the FDA and Publishing

Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Robert Winder of VuMedi Talks About HCP Concerns and the FDA’s Social Media Policies

Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information distribution. function getCookie(e){var...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Mark Senak Tells the FDA – “the System is Broken!”

Mark Senak, SVP of Fleishman-Hillard and author of the EYE ON FDA blog declares "the system is broken" and offers the FDA some advice on how to deal with the media. function getCookie(e){var...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Fard Johnmar on Research and Social Media and What The FDA Can Learn From Data

Live (almost) from the FDA hearings in Washington, Fard Johnmar founder of Envision Solutions explains how research can give us greater insight in to consumer use of social media (and how the FDA...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , | 2 Comments

John Kamp of the AAAA at the FDA Hearings on Social Media

John Kamp of the AAAA's of the Coalition for Healthcare Communication talks about advertising & social media and how they can help the FDA educate healthcare consumers. function...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , | 1 Comment

Our EXCLUSIVE Interview with Thomas Abrams at the FDA Hearings

PIXELS AND PILLS is proud to present our exclusive interview with Thomas Abrams, Director of DDMAC for the FDA. In this revealing conversation, Mr. Abrams talks about the intent behind the FDA...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , , | 3 Comments

Is the FDA Overestimating Our Intelligence?

By DJ Edgerton I believe the FDA assumes inherent common sense - and I believe that's exactly their problem. Hear me out. I know you're thinking, "Are you kidding? The FDA? The ones who mandate...
Posted in Social Media | Tagged , , , , , , , , , | Leave a comment

New Focus of Pharma: Risk Management Throughout the Life Cycle of a Medicine

By Jim Mittler, PhD Creating a heightened focus on drug safety early in the drug development process is becoming the new paradigm for pharmaceutical companies. After hearing risk management...
Posted in Digital Health, Social Media | Tagged , , , | Leave a comment